4 European Projects Found
Searched on 125080 European Projects
FINISHED
Molecular Tools for Nucleic Acid Manipulation for Biological Intervention (MMBio)
Start date: Jan 1, 2017, End date: Dec 31, 2020,
MMbio will bridge the classically separate disciplines of Chemistry and Biology by assembling leading experts from academia and non-academic partners (industry, technology transfer & science communication) to bring about systems designed to interfere therapeutically with gene expression in living cells. Expertise in nucleic acid synthesis, its molecular recognition and chemical reactivity is combi ...
Read Project
13
Partners Participants
FINISHED
European Gram Negative Antibacterial Engine (ENABLE)
Start date: Feb 1, 2014, End date: Jan 31, 2020,
...idable consequence of antibiotic use and therefore new, effective antibacterials will always be needed and once developed should be used carefully, avoiding the overuse which can drive resistance. Despite the recognized need for new antimicrobials for clinical use, the reality is that only two new classes of antibiotics have been brought to market in the last 30 years and many drug developers hav ...
Read Project
42
Partners Participants
FINISHED
Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases (FORMAMP)
Start date: Dec 1, 2013, End date: Nov 30, 2017,
...eginning of the last century. Antimicrobial peptides (AMPs) have a huge potential as new therapeutics against infectious diseases as they are less prone to induce resistance due to their fast and non-specific mechanism of action. The aim of FORMAMP is to explore a number of innovative formulation and delivery strategies based on nanotechnology in order to improve the efficiency and stability of AM ...
Read Project
18
Partners Participants
FINISHED
Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration (DRUGSFORD)
Start date: Sep 1, 2012, End date: Aug 31, 2016,
...reventing photoreceptor damage in preclinical disease models. Towards this goal, two SMEs have teamed up with three academic research groups focused on retinal degeneration: the German company BIOLOG specializes on development of cyclic nucleotide based drugs targeting PKG, CNGC, and GC; the Dutch company to-BBB develops systems to deliver drugs across the blood brain/retinal barrier (BBB, BRB, re ...
Read Project
